Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$335K Buy
+926
New +$317K 0.21% 32
2025
Q3
$281K Buy
995
+2
+0.2% +$580 0.17% 42
2025
Q2
$277K Buy
993
+5
+0.5% +$1.42K 0.17% 38
2025
Q1
$308K Sell
988
-15
-1% -$4.43K 0.28% 30
2024
Q4
$261K Buy
1,003
+1
+0.1% +$297 0.21% 37
2024
Q3
$316K Hold
1,002
0.21% 36
2024
Q2
$326K Hold
1,002
0.24% 30
2024
Q1
$285K Hold
1,002
0.23% 35
2023
Q4
$289K Buy
+1,002
New +$273K 0.29% 32

Other funds holding AMGN

Gimbal Financial's AMGN Position: Q2 2026 in Review

Gimbal Financial opened a new position in Amgen (AMGN) in Q2 2026: 926 shares worth $335K. The stake represents 0.21% of the portfolio and ranks #32 among its holdings. This is a return to the name: Gimbal Financial previously reported a position in AMGN as recently as Q3 2025.

Gimbal Financial first reported a position in AMGN in Q4 2023 and has held it in 9 quarters since. 3,157 funds tracked by Wall St. Rank hold AMGN as of Q2 2026.

  • Gimbal Financial held 926 shares of Amgen worth $335K as of Q2 2026.
  • Amgen was a new Gimbal Financial position in Q2 2026.
  • Amgen made up 0.21% of Gimbal Financial's portfolio in Q2 2026, its #32 holding.
  • Gimbal Financial first reported a position in Amgen in Q4 2023 and has held it in 9 quarters since.
  • 3,157 funds tracked by Wall St. Rank held Amgen as of Q2 2026.

Based on Gimbal Financial's 13F filing for Q2 2026, filed 4 Aug 2026.